Obsurge Biotech Limited, a active public limited company, was established on 04 January 2002 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2002PLC113701. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.82 M.
It upholds a compliant status. Employing 606 professional, Its leadership includes Avijit Chauhan (Managing Director), Amin Ul Aziz (Director), Jaswant Singh Chauhan (Director). Past directors included Avijit Chauhan, Sheelawanti Chauhan, Amin Ul Aziz. It holds ₹2.59 M open charges and ₹5.02 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101-102 Aditya Tower District Centre Laxmi Nagar, Delhi, Delhi, 110092.
U24232DL2002PLC113701
113701
04 January 2002
₹3.00 M
₹2.82 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Obsurge Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avijit Chauhan | Managing Director | 07 Jan 2008 | Current |
| Amin Ul Aziz | Director | 03 Apr 2015 | Current |
| Jaswant Singh Chauhan | Director | 04 Jan 2002 | Current |
| Latish Malhotra | Whole-Time Director | 04 Jan 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 04 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Managing Director | 31 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Obsurge Biotech Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Obsurge Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,588,000.00
₹50,192,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2022 | Hdfc Bank Limited | ₹2.59 M | Open |
| 30 May 2018 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
| 28 Feb 2013 | Citibank N.A | ₹1.50 Cr | Satisfied |
| 02 Sep 2002 | Union Bank Of India | ₹1.52 Cr | Satisfied |
Explore comprehensive loan charge details -
Obsurge Biotech has a workforce of 606 employees as of Sep 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Obsurge Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Obsurge Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Obsurge Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Obsurge Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge registered on 30 May 2018 via Charge ID 100202488 with Hdfc Bank Limited was fully satisfied on 02 Mar 2024. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.59 M with Charge ID 100565326 was registered on 29 Mar 2022. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 20.00 M with Charge ID 100202488 was registered on 30 May 2018. was completed.
Amin Ul Aziz was appointed as a Director was appointed as a Director on 03 Apr 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
The CIN of Obsurge Biotech Limited is U24232DL2002PLC113701.
Obsurge Biotech Limited is headquartered at 101-102 Aditya Tower District Centre Laxmi Nagar, Delhi, Delhi, 110092.
Obsurge Biotech Limited was incorporated on 04 January 2002.
The current directors of Obsurge Biotech Limited are
The primary industry of Obsurge Biotech Limited is Trade.
Obsurge Biotech Limited is unlisted.
The authorized capital of Obsurge Biotech Limited is ₹3.00 M, and the paid-up capital is ₹2.82 M.
The compliance status of Obsurge Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX